BCTXL BriaCell Therapeutics Corp.
NEUTRAL
Impact: 3/10
PRESS-RELEASE
Press release: earnings
Price Chart
Loading chart...
Executive Summary
BriaCell Therapeutics held its annual shareholder meeting on March 5, 2026, reappointing auditors and electing directors with strong shareholder support. No financial results or operational updates were disclosed, and the filing is primarily administrative in nature.
Actionable Insight
No immediate trading implications. Monitor upcoming clinical trial updates or future earnings releases for material developments.
Key Facts
- Annual general meeting held on March 5, 2026 for fiscal year ended July 31, 2025
- 48.31% of issued and outstanding shares voted
- MNP LLP reappointed as auditors
- Six directors elected with 97.36% to 97.92% of votes in favor
- No financial results, guidance, or material operational updates disclosed
Financial Impact
No material financial impact disclosed
Risk Factors
- Lack of disclosed financial performance data limits assessment of company health
- Low shareholder turnout (48.31%) may reflect limited investor engagement
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3250650 |
8 reports for BCTXL
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 26, 2026
19d ago
|
Press Release
| — | awaiting T+20 | — | — |
|
May 22, 2026
23d ago
|
Press Release
| — | awaiting T+20 | — | — |
|
May 13, 2026
4w ago
|
Press Release
| $1.08 awaiting T+20 | awaiting T+20 | — | — |
|
May 6, 2026
5w ago
|
Press Release
| — | awaiting T+20 | — | — |
|
Apr 21, 2026
7w ago
|
Press Release
| — | awaiting T+20 | — | — |
|
Apr 20, 2026
7w ago
|
Press Release
| — | awaiting T+20 | — | — |
|
Mar 18, 2026
12w ago
|
Press Release
| — | awaiting T+20 | — | — |
|
Mar 5, 2026
14w ago
|
Press Release
| — | awaiting T+20 | — | — |
Showing 8 of 8
US Market Status
Market Closed — Opens in 4h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access